United States Securities and Exchange Commission · EDGAR Accession 0001872856-25-000006

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2053710
Raising via DEALMAKER SECURITIES LLC

RAM Pharmaceuticals Inc.

CorporationDEIncorporated 2024LUMBERTON, MSrampharmaceuticals.com
A

The Offering

as disclosed in this filing
Other (Series B Common Stock)
$1.00
$10,200
$1,235,000
January 16, 2026
Expired 149 days ago
$0max $1,235,000

Target is 1% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 220%2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(33,481)0
Total assets27,8570
Cash & equivalents23,4380
Accounts receivable7,4450
Short-term debt61,3380
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.